Literature DB >> 21711325

Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis.

C Pouplard1, P-A Gourraud, N Meyer, C B Livideanu, M Lahfa, J Mazereeuw-Hautier, P Le Jeunne, A-L Sabatini, C Paul.   

Abstract

BACKGROUND: Unclear instructions probably contribute to the suboptimal efficacy and adherence to topical agents in psoriasis.
OBJECTIVES: To analyse the quality of prescriptions for topical therapy in psoriasis and to determine factors associated with high-quality prescription writing.
METHODS: We made a systematic analysis of 767 topical prescriptions written by dermatologists and general practitioners (GPs). The following parameters were recorded: writing mode (electronic vs. hand written), indication of formulation, frequency of administration, duration of treatment, indication of areas to be treated, and indication of amount of product to be used. We considered prescriptions of high quality to be those including at least four of the five prospectively defined quality parameters.
RESULTS: Only 35·7% of prescriptions fulfilled the definition of a high-quality prescription. Quality of prescription writing was significantly influenced by two factors: electronic writing [odds ratio (OR) 3·04, 95% confidence interval (CI) 2·2-4·21; P < 10(-4) ] and specialty of the prescriber, dermatologists writing higher quality prescriptions compared with GPs (OR 1·61, 95% CI 1·54-2·14; P < 10(-4) ).
CONCLUSIONS: Almost two-thirds of topical prescriptions are not adequately written and do not include the required information to help patients manage their topical treatment in psoriasis correctly. The quality of topical prescriptions could be improved by making the use of electronic prescriptions widespread and by the development of aids for easy evaluation of the right amount of topical treatment to be applied according to body surface area involved.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711325     DOI: 10.1111/j.1365-2133.2011.10480.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Clinical study on the effects of the applied volume of moisturizer in patients with asteatosis.

Authors:  Yuichiro Tsunemi; Haruka Nakahigashi
Journal:  J Dermatol       Date:  2021-09-21       Impact factor: 3.468

Review 2.  [Adequate prescription and application of topicals : How to calculate the right volume for the prescription of ointment needed?]

Authors:  D Homayoon; P Dahlhoff; M Augustin
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

3.  How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey.

Authors:  Anna Graziella Burroni; Mariella Fassino; Antonio Torti; Elena Visentin
Journal:  Patient Relat Outcome Meas       Date:  2015-02-16

4.  Towards Better CARE for Superficial Fungal Infections: A Consultation Guide for the Community Pharmacy.

Authors:  Pantira Parinyarux; Wiwat Thavornwattanayong; Cheardchai Soontornpas; Peeranon Rawangnam
Journal:  Pharmacy (Basel)       Date:  2022-02-11

5.  Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.

Authors:  James M Mason; Julie Carr; Carolyn Buckley; Steve Hewitt; Phillip Berry; Josh Taylor; Michael J Cork
Journal:  BMC Dermatol       Date:  2013-05-16

6.  Knowledge and Practices of Community Pharmacists in Topical Dermatological Treatments.

Authors:  Ana Teixeira; Maribel Teixeira; Maria Teresa Herdeiro; Viviana Vasconcelos; Rita Correia; Maria Fernanda Bahia; Isabel F Almeida; Diogo Guedes Vidal; Hélder Fernando Pedrosa E Sousa; Maria Alzira Pimenta Dinis; Vera Almeida
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.